6 нояб. 2024 г. · memantine hydrochloride tablet;oral · Manufacturer: ACME LABS Approval date: May 7, 2018 · Manufacturer: AJANTA PHARMA LTD Approval date: ...

17 февр. 2014 г. · It plans to discontinue the sale of NAMENDA® (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.

NAMENDA was evaluated in eight double-blind placebo-controlled trials involving a total of 1862 dementia (Alzheimer's disease, vascular dementia) patients (940 ...

4 апр. 2002 г. · Namenda (Memantine HCI) Tablets. Company: Forest Laboratories Inc. Application No.: 021487. Approval Date: 10/16/2003. Date created: April 04, 2002.

6 нояб. 2024 г. · Generic drug availability, manufacturer information, and patent status on Namenda XR.

See full prescribing information for NAMENDA XR capsules. NAMENDA XR® (memantine hydrochloride) extended-release capsules, for oral use. Initial U.S. Approval: ...

24 дек. 2019 г. · The purchasers accused Allergan's Forest Laboratories unit of paying a rival to delay selling generic Namenda IR and encouraging them to switch ...

9 окт. 2023 г. · Memantine is marketed for the treatment of moderate to severe Alzheimer's disease in the United States, Canada, Europe, China, and other countries.

NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. 2. DOSAGE AND ADMINISTRATION. The ...